Prestige BioPharma (950210) Net Assets

950210 Net Assets in 2023: $546.23B

As of 13 Sept 2024, Prestige BioPharma net assets is $546.23B, an increase of 27.05% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Prestige BioPharma overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.

Prestige BioPharma Net Assets History from 2020 to 2024

950210 Net Assets History by year

View the Top Net Assets Companies